-
ZimVie's 2021 revenue, NuVasive wins $1.6M and more: 6 device company notes
NuVasive's court win, payer approval of artificial disc replacement and four more updates from spine devicemakers in the last week: -
Devicemaker raises $23M to grow delivery of personalized implants
Restor3d, a musculoskeletal devicemaker, raised $23 million to expand the delivery of personalized 3D-printed implants and to develop software for engineers. -
SpineGuard's anterior spine device cleared for commercial launch
SpineGuard's PediGuard threaded instrument was cleared by the FDA for anterior approach spine procedures, the devicemaker said April 4. -
What 3 spine device COOs are paid
Chief operating officers are top-ranking executives tasked with overseeing administrative functions at a business. -
Why 6 spine surgeons are excited about augmented reality
Interest in augmented reality has spiked over the past decade, stemming from a desire to limit complications associated with instrumented spine surgery and improve procedural efficiency. -
Dr. Stefan Renaud debuts 15-degree spine implant
Stefan Renaud, DO, performed the first case with Amplify Surgical's 15-degree lordotic DualX interbody fusion implant. -
ZimVie sees $1B in 2021 revenue: 4 notes
ZimVie, Zimmer Biomet's spine and dental spinoff company, cracked $1 billion in third-party revenue and is on track to see similar results in 2022. -
NuVasive wins $1.6M after former employee breaches contract
A judge with the U.S. District Court of the District of Massachusetts awarded NuVasive $1.6 million in damages after finding a former employee of the devicemaker breached his noncompete and nonsolicitation clauses, Mondaq reported March 31. -
Top-paid CFOs, SeaSpine's milestone and more: 6 device company notes
Life Spine's latest FDA clearance and five more updates from spine medtech companies in the last week: -
The most innovative spine companies in 2022
Many exciting innovations are being developed in the spine device industry, with smaller companies and startups aiming to break into a market dominated by medtech giants such as Medtronic, Stryker and Johnson & Johnson. -
5 spine, orthopedic medtech acquisitions making a splash in Q1
Five spine and orthopedic medtech companies completed or announced acquisitions in the first quarter of 2022. -
Sacroiliac joint fixation system gets additional FDA approval
Life Spine's sacroiliac joint fixation system, SImpact, received FDA clearance for posterior-oblique surgical approaches, the devicemaker said March 29. -
9 spine devices cleared by the FDA
The FDA granted nine orthopedic device approvals in February: -
9 highest-paid CFOs in the spine device industry
CFOs hold the top financial position in a company and are responsible for projecting the organization's financial standing as well as advising the CEO and board on strategic direction. -
Zimmer Biomet in Q1: 4 key developments
From the separation of its spine and dental businesses to its latest commercial product launch, here are four key developments from Zimmer Biomet in the first quarter: -
Spine devicemaker hits 20K artificial disc implantations, eyes U.S. market
France-based Spine Innovations reached a milestone with its lumbar disc replacement device, and it's setting its sights on the U.S. market. -
Globus Medical co-founder joins spine medtech board
Globus Medical co-founder Andrew Iott is among two new additions to Happe Spine's board of directors. -
Stryker in Q1: 5 notes
A $3.1 billion acquisition and four more developments from Stryker in the first quarter of 2022: -
SeaSpine hits 50K NanoMetalene implantations
SeaSpine's NanoMetalene technology was implanted in its 50,000th case, the devicemaker said in a March 24 news release. -
Former Zimmer Biomet, Amazon leaders join Assure Holdings
Intraoperative neuromonitoring company Assure Holdings hired two executives.
Page 38 of 189